Redefining Relief: Emerging Innovations in the Management of Pulmonary Arterial Hypertension

Gain in-depth knowledge on the pathophysiology of pulmonary arterial hypertension (PAH), current guideline-directed treatment options, and emerging evidence on novel therapies to better treat patients and manage their care.

Share

Program Content

Activities

PAH Management
What Healthcare Professionals Need to Know About Diagnosing and Treating PAH
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2024

Expires: March 26, 2025

Activities

Innovations in Pulmonary Arterial Hypertension
Redefining Relief: Emerging Innovations in the Management of Pulmonary Arterial Hypertension
Video
Congratulations: You achieved a completion on 04/09/2022

Released: September 04, 2024

Expires: September 03, 2025

Activities

Pulmonary Arterial Hypertension
Redefining Relief: Emerging Innovations in the Management of Pulmonary Arterial Hypertension
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 09, 2024

Expires: May 08, 2025

Faculty

cover img faculity

Vallerie V. McLaughlin, MD

Kim A. Eagle, MD Endowed Professor of Cardiovascular Medicine
Interim Chief Clinical Officer, Ambulatory Care Services
Director, Pulmonary Hypertension Program
Michigan Medicine
Ann Arbor, Michigan

cover img faculity

Corinne Young, MSN, FNP-C, FCCP

President
The Association of Pulmonary Advanced Practice Providers
Colorado Springs, Colorado

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA